Cargando…
Cancer immunohistogram representing cancer-immunity cycle by immunohistochemistry predicts the efficacy of immune checkpoint inhibitors in urological cancer patients
We developed an immunohistogram representing an individual cancer-immunity cycle based on immunohistochemical analyses. We evaluated its ability to predict the efficacy of immune checkpoint inhibitors (ICI) in 11 patients with urothelial carcinoma and 7 patients with renal cell carcinoma who underwe...
Autores principales: | Kijima, Toshiki, Kubo, Terufumi, Nishihara, Daisaku, Nukui, Akinori, Hirohashi, Yoshihiko, Torigoe, Toshihiko, Kamai, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226007/ https://www.ncbi.nlm.nih.gov/pubmed/35739295 http://dx.doi.org/10.1038/s41598-022-14700-1 |
Ejemplares similares
-
Fundamental and Essential Knowledge for Pathologists Engaged in the Research and Practice of Immune Checkpoint Inhibitor-Based Cancer Immunotherapy
por: Kubo, Terufumi, et al.
Publicado: (2021) -
Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma
por: Nishihara, Daisaku, et al.
Publicado: (2023) -
Immune responses to human cancer stem‐like cells/cancer‐initiating cells
por: Hirohashi, Yoshihiko, et al.
Publicado: (2015) -
Successful management of ureteral injury after gender-affirming laparoscopic hysterectomy: A case report
por: Nakamura, Gaku, et al.
Publicado: (2022) -
Presurgical avelumab plus axitinib in an immunosenescent octogenarian with renal cell carcinoma invading the vena cava
por: Uematsu, Toshitaka, et al.
Publicado: (2022)